Tags

Type your tag names separated by a space and hit enter

[Anti-virals for influenza virus infection].
Uirusu 2005; 55(1):111-4U

Abstract

Dramatic advances in the diagnosis and treatment of influenza in Japan has been made in recent years. Rapid diagnosis tests for influenza are routinely performed in Japanese hospitals. Both zanamivir and oseltamivir have been approved for the treatment of influenza since 2001, in addition to amantadine. Japan has the highest figure of neuraminidase inhibitor-use in the world because the treatment of influenza with neuraminidase inhibitors is covered by Japan's National Health Insurance program. Therefore, we should carefully observe the appearance of resistance strains and side effects to neuraminidase inhibitors.

Authors+Show Affiliations

Department of Pediatrics, Keiyu Hospital, Kanagawa, Japan.

Pub Type(s)

English Abstract
Journal Article
Review

Language

jpn

PubMed ID

16308537

Citation

Sugaya, Norio. "[Anti-virals for Influenza Virus Infection]." Uirusu, vol. 55, no. 1, 2005, pp. 111-4.
Sugaya N. [Anti-virals for influenza virus infection]. Uirusu. 2005;55(1):111-4.
Sugaya, N. (2005). [Anti-virals for influenza virus infection]. Uirusu, 55(1), pp. 111-4.
Sugaya N. [Anti-virals for Influenza Virus Infection]. Uirusu. 2005;55(1):111-4. PubMed PMID: 16308537.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Anti-virals for influenza virus infection]. A1 - Sugaya,Norio, PY - 2005/11/26/pubmed PY - 2006/1/28/medline PY - 2005/11/26/entrez SP - 111 EP - 4 JF - Uirusu JO - Uirusu VL - 55 IS - 1 N2 - Dramatic advances in the diagnosis and treatment of influenza in Japan has been made in recent years. Rapid diagnosis tests for influenza are routinely performed in Japanese hospitals. Both zanamivir and oseltamivir have been approved for the treatment of influenza since 2001, in addition to amantadine. Japan has the highest figure of neuraminidase inhibitor-use in the world because the treatment of influenza with neuraminidase inhibitors is covered by Japan's National Health Insurance program. Therefore, we should carefully observe the appearance of resistance strains and side effects to neuraminidase inhibitors. SN - 0042-6857 UR - https://www.unboundmedicine.com/medline/citation/16308537/[Anti_virals_for_influenza_virus_infection]_ L2 - http://japanlinkcenter.org/JST.JSTAGE/jsv/55.111?lang=en&from=PubMed DB - PRIME DP - Unbound Medicine ER -